22266487 9709382 14734689 8713487 19683970 21831726 9085464 15606399 28300821 28183317 16595587 19707261 10190932 12830451 19352190 32800653 25210613 19589743 8985838 21753892 8732732 8788291 15812451 23055859 9354210 16540792 20477294 7472816 211970 - Search Results

Year	Number of Results
1995	3
1996	4
1997	3
1998	1
1999	1
2003	2
2004	2
2005	2
2006	2
2007	1
2008	2
2009	4
2010	2
2011	2
2012	2
2013	2
2017	2
2020	3
2021	1
2022	0

1

Liprotamase long-term safety and support of nutritional status in pancreatic-insufficient cystic fibrosis.

Borowitz D, Stevens C, Brettman LR, Campion M, Wilschanski M, Thompson H; Liprotamase 767 Study Group. Borowitz D, et al. J Pediatr Gastroenterol Nutr. 2012 Feb;54(2):248-57. doi: 10.1097/MPG.0b013e31823315d1. J Pediatr Gastroenterol Nutr. 2012. PMID: 22266487 Clinical Trial.

2

Uses and abuses of enzyme therapy in cystic fibrosis.

Durie P, Kalnins D, Ellis L. Durie P, et al. J R Soc Med. 1998;91 Suppl 34(Suppl 34):2-13. doi: 10.1177/014107689809134s02. J R Soc Med. 1998. PMID: 9709382 Free PMC article. Review. No abstract available.

3

Cystic fibrosis adult care: consensus conference report.

Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D. Yankaskas JR, et al. Chest. 2004 Jan;125(1 Suppl):1S-39S. doi: 10.1378/chest.125.1_suppl.1s. Chest. 2004. PMID: 14734689 Review. No abstract available.

4

Adverse drug events related to dosage forms and delivery systems.

Uchegbu IF, Florence AT. Uchegbu IF, et al. Drug Saf. 1996 Jan;14(1):39-67. doi: 10.2165/00002018-199614010-00005. Drug Saf. 1996. PMID: 8713487 Review.

5

EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency.

Wooldridge JL, Heubi JE, Amaro-Galvez R, Boas SR, Blake KV, Nasr SZ, Chatfield B, McColley SA, Woo MS, Hardy KA, Kravitz RM, Straforini C, Anelli M, Lee C. Wooldridge JL, et al. J Cyst Fibros. 2009 Dec;8(6):405-17. doi: 10.1016/j.jcf.2009.07.006. Epub 2009 Aug 15. J Cyst Fibros. 2009. PMID: 19683970 Free article. Clinical Trial.

6

International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients.

Borowitz D, Stevens C, Brettman LR, Campion M, Chatfield B, Cipolli M; Liprotamase 726 Study Group. Borowitz D, et al. J Cyst Fibros. 2011 Dec;10(6):443-52. doi: 10.1016/j.jcf.2011.07.001. Epub 2011 Aug 9. J Cyst Fibros. 2011. PMID: 21831726 Free article. Clinical Trial.

7

Carboxyl ester lipase (bile salt-stimulated lipase), colipase, lipase, and phospholipase A2 levels in pancreatic enzyme supplements.

Sternby B, Nilsson A. Sternby B, et al. Scand J Gastroenterol. 1997 Mar;32(3):261-7. doi: 10.3109/00365529709000204. Scand J Gastroenterol. 1997. PMID: 9085464

8

Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.

Konstan MW, Stern RC, Trout JR, Sherman JM, Eigen H, Wagener JS, Duggan C, Wohl ME, Colin P. Konstan MW, et al. Aliment Pharmacol Ther. 2004 Dec;20(11-12):1365-71. doi: 10.1111/j.1365-2036.2004.02261.x. Aliment Pharmacol Ther. 2004. PMID: 15606399 Free article. Clinical Trial.

9

Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation.

Gelfond D, Heltshe S, Ma C, Rowe SM, Frederick C, Uluer A, Sicilian L, Konstan M, Tullis E, Roach RN, Griffin K, Joseloff E, Borowitz D. Gelfond D, et al. Clin Transl Gastroenterol. 2017 Mar 16;8(3):e81. doi: 10.1038/ctg.2017.10. Clin Transl Gastroenterol. 2017. PMID: 28300821 Free PMC article.

10

Practical guide to exocrine pancreatic insufficiency - Breaking the myths.

Struyvenberg MR, Martin CR, Freedman SD. Struyvenberg MR, et al. BMC Med. 2017 Feb 10;15(1):29. doi: 10.1186/s12916-017-0783-y. BMC Med. 2017. PMID: 28183317 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results